Table 3. Drug treatments of Pts at enrollment.

	Total	Soft	Mix	P
Antiplatelet drugs	42/50	18/22	24/28	0.718
Statins	33/50	14/22	19/28	0.773
β-blockers	16/50	7/22	9/28	1.000
ACE inhibitors/AT1R-antagonists	26/50	11/22	15/28	1.000
Ca++-channel blockers	16/50	7/22	9/28	1.000
Diuretics	9/50	3/22	6/28	0.713
Hypoglycemic drugs	5/50	3/22	2/28	0.643
Other drugs	27/50	13/22	14/28	0.577

P indicates statistical significance on the differences between soft and mix plaques.